aluates Reports

$ 0.0

Automative

Global Dengue Vaccines Market Research Report 2026

Published Date: 2026-02-25

Report Code: QYRE-Auto-25Q8996

Global Dengue Vaccines Market Size Status and Forecast 2022

BUY CHAPTERS

Global Dengue Vaccines Market Research Report 2026

Code: QYRE-Auto-25Q8996

Report

2026-02-25

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi

Takeda

Dengue Vaccines Market Size

The global Dengue Vaccines market was valued at US$ 591 million in 2025 and is anticipated to reach US$ 1486 million by 2032, at a CAGR of 14.3% from 2026 to 2032.

Dengue Vaccines Market

Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.

The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.

This report delivers a comprehensive overview of the global Dengue Vaccines market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Dengue Vaccines. The Dengue Vaccines market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Dengue Vaccines market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Dengue Vaccines manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Dengue Vaccines Market Report

Report Metric	Details
Report Name	Dengue Vaccines Market
Accounted market size in 2025	US$ 591 in million
Forecasted market size in 2032	US$ 1486 million
CAGR	14.3%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Dengvaxia TAK-003 Others
Segment by Application	Public Sector Private Sector
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sanofi, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Dengue Vaccines companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Dengue Vaccines Market growing?

Ans: The Dengue Vaccines Market witnessing a CAGR of 14.3% during the forecast period 2026-2032.

What is the Dengue Vaccines Market size in 2032?

Ans: The Dengue Vaccines Market size in 2032 will be US$ 1486 million.

Who are the main players in the Dengue Vaccines Market report?

Ans: The main players in the Dengue Vaccines Market are Sanofi, Takeda

What are the Application segmentation covered in the Dengue Vaccines Market report?

Ans: The Applications covered in the Dengue Vaccines Market report are Public Sector, Private Sector

What are the Type segmentation covered in the Dengue Vaccines Market report?

Ans: The Types covered in the Dengue Vaccines Market report are Dengvaxia, TAK-003, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Dengue Vaccines Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Dengvaxia

1.2.3 TAK-003

1.2.4 Others

1.3 Market by Application

1.3.1 Global Dengue Vaccines Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Public Sector

1.3.3 Private Sector

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Dengue Vaccines Market Perspective (2021–2032)

2.2 Global Dengue Vaccines Growth Trends by Region

2.2.1 Global Dengue Vaccines Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Dengue Vaccines Historic Market Size by Region (2021–2026)

2.2.3 Dengue Vaccines Forecasted Market Size by Region (2027–2032)

2.3 Dengue Vaccines Market Dynamics

2.3.1 Dengue Vaccines Industry Trends

2.3.2 Dengue Vaccines Market Drivers

2.3.3 Dengue Vaccines Market Challenges

2.3.4 Dengue Vaccines Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Dengue Vaccines Players by Revenue

3.1.1 Global Top Dengue Vaccines Players by Revenue (2021–2026)

3.1.2 Global Dengue Vaccines Revenue Market Share by Players (2021–2026)

3.2 Global Top Dengue Vaccines Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Dengue Vaccines Revenue

3.4 Global Dengue Vaccines Market Concentration Ratio

3.4.1 Global Dengue Vaccines Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Dengue Vaccines Revenue in 2025

3.5 Global Key Players of Dengue Vaccines Head Offices and Areas Served

3.6 Global Key Players of Dengue Vaccines, Products and Applications

3.7 Global Key Players of Dengue Vaccines, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Dengue Vaccines Breakdown Data by Type

4.1 Global Dengue Vaccines Historic Market Size by Type (2021–2026)

4.2 Global Dengue Vaccines Forecasted Market Size by Type (2027–2032)

5 Dengue Vaccines Breakdown Data by Application

5.1 Global Dengue Vaccines Historic Market Size by Application (2021–2026)

5.2 Global Dengue Vaccines Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Dengue Vaccines Market Size (2021–2032)

6.2 North America Dengue Vaccines Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Dengue Vaccines Market Size by Country (2021–2026)

6.4 North America Dengue Vaccines Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Dengue Vaccines Market Size (2021–2032)

7.2 Europe Dengue Vaccines Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Dengue Vaccines Market Size by Country (2021–2026)

7.4 Europe Dengue Vaccines Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Dengue Vaccines Market Size (2021–2032)

8.2 Asia-Pacific Dengue Vaccines Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Dengue Vaccines Market Size by Region (2021–2026)

8.4 Asia-Pacific Dengue Vaccines Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Dengue Vaccines Market Size (2021–2032)

9.2 Latin America Dengue Vaccines Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Dengue Vaccines Market Size by Country (2021–2026)

9.4 Latin America Dengue Vaccines Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Dengue Vaccines Market Size (2021–2032)

10.2 Middle East & Africa Dengue Vaccines Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Dengue Vaccines Market Size by Country (2021–2026)

10.4 Middle East & Africa Dengue Vaccines Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sanofi

11.1.1 Sanofi Company Details

11.1.2 Sanofi Business Overview

11.1.3 Sanofi Dengue Vaccines Introduction

11.1.4 Sanofi Revenue in Dengue Vaccines Business (2021–2026)

11.1.5 Sanofi Recent Development

11.2 Takeda

11.2.1 Takeda Company Details

11.2.2 Takeda Business Overview

11.2.3 Takeda Dengue Vaccines Introduction

11.2.4 Takeda Revenue in Dengue Vaccines Business (2021–2026)

11.2.5 Takeda Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sanofi

Takeda

List of Tables

Table 1. Global Dengue Vaccines Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Dengvaxia

Table 3. Key Players of TAK-003

Table 4. Key Players of Others

Table 5. Global Dengue Vaccines Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Dengue Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Dengue Vaccines Market Size by Region (US$ Million), 2021–2026

Table 8. Global Dengue Vaccines Market Share by Region (2021–2026)

Table 9. Global Dengue Vaccines Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Dengue Vaccines Market Share by Region (2027–2032)

Table 11. Dengue Vaccines Market Trends

Table 12. Dengue Vaccines Market Drivers

Table 13. Dengue Vaccines Market Challenges

Table 14. Dengue Vaccines Market Restraints

Table 15. Global Dengue Vaccines Revenue by Players (US$ Million), 2021–2026

Table 16. Global Dengue Vaccines Market Share by Players (2021–2026)

Table 17. Global Top Dengue Vaccines Players by Tier (Tier 1, Tier 2, and Tier 3), based on Dengue Vaccines Revenue, 2025

Table 18. Ranking of Global Top Dengue Vaccines Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Dengue Vaccines Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Dengue Vaccines, Headquarters and Area Served

Table 21. Global Key Players of Dengue Vaccines, Products and Applications

Table 22. Global Key Players of Dengue Vaccines, Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Dengue Vaccines Market Size by Type (US$ Million), 2021–2026

Table 25. Global Dengue Vaccines Revenue Market Share by Type (2021–2026)

Table 26. Global Dengue Vaccines Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Dengue Vaccines Revenue Market Share by Type (2027–2032)

Table 28. Global Dengue Vaccines Market Size by Application (US$ Million), 2021–2026

Table 29. Global Dengue Vaccines Revenue Market Share by Application (2021–2026)

Table 30. Global Dengue Vaccines Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Dengue Vaccines Revenue Market Share by Application (2027–2032)

Table 32. North America Dengue Vaccines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Dengue Vaccines Market Size by Country (US$ Million), 2021–2026

Table 34. North America Dengue Vaccines Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Dengue Vaccines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Dengue Vaccines Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Dengue Vaccines Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Dengue Vaccines Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Dengue Vaccines Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Dengue Vaccines Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Dengue Vaccines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Dengue Vaccines Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Dengue Vaccines Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Dengue Vaccines Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Dengue Vaccines Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Dengue Vaccines Market Size by Country (US$ Million), 2027–2032

Table 47. Sanofi Company Details

Table 48. Sanofi Business Overview

Table 49. Sanofi Dengue Vaccines Product

Table 50. Sanofi Revenue in Dengue Vaccines Business (US$ Million), 2021–2026

Table 51. Sanofi Recent Development

Table 52. Takeda Company Details

Table 53. Takeda Business Overview

Table 54. Takeda Dengue Vaccines Product

Table 55. Takeda Revenue in Dengue Vaccines Business (US$ Million), 2021–2026

Table 56. Takeda Recent Development

Table 57. Research Programs/Design for This Report

Table 58. Key Data Information from Secondary Sources

Table 59. Key Data Information from Primary Sources

Table 60. Authors List of This Report

List of Figures

Figure 1. Dengue Vaccines Picture

Figure 2. Global Dengue Vaccines Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Dengue Vaccines Market Share by Type: 2025 vs 2032

Figure 4. Dengvaxia Features

Figure 5. TAK-003 Features

Figure 6. Others Features

Figure 7. Global Dengue Vaccines Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Dengue Vaccines Market Share by Application: 2025 vs 2032

Figure 9. Public Sector Case Studies

Figure 10. Private Sector Case Studies

Figure 11. Dengue Vaccines Report Years Considered

Figure 12. Global Dengue Vaccines Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Dengue Vaccines Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Dengue Vaccines Market Share by Region: 2025 vs 2032

Figure 15. Global Dengue Vaccines Market Share by Players in 2025

Figure 16. Global Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Dengue Vaccines Revenue in 2025

Figure 18. North America Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Dengue Vaccines Market Share by Country (2021–2032)

Figure 20. United States Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Dengue Vaccines Market Share by Country (2021–2032)

Figure 24. Germany Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Dengue Vaccines Market Share by Region (2021–2032)

Figure 32. China Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Dengue Vaccines Market Share by Country (2021–2032)

Figure 40. Mexico Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Dengue Vaccines Market Share by Country (2021–2032)

Figure 44. Israel Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Dengue Vaccines Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Sanofi Revenue Growth Rate in Dengue Vaccines Business (2021–2026)

Figure 48. Takeda Revenue Growth Rate in Dengue Vaccines Business (2021–2026)

Figure 49. Bottom-up and Top-down Approaches for This Report

Figure 50. Data Triangulation

Figure 51. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Human Rabies Vaccine Market Research Report 2024

Malaria Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dengue Virus Testing Market Research Report 2025

Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cervical Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Coccidiosis Vaccine for Chickens Market Research Report 2024

Global Yellow Fever Vaccination Market Research Report 2025

Global Yellow Fever Vaccines Market Insights Forecast to 2030

Duck Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dengue Fever Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dengue Rapid Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global DPT Vaccines Market Research Report 2025

Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Rabies Vaccination Market Research Report 2025

Global DPT Vaccination Market Research Report 2025

Global Marek s Disease Vaccine Market Research Report 2024

Global DTaP and Tdap Vaccines Market Insights Forecast to 2030

Chicken Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions